4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001209191-14-051194
Director bought 3,000 shares at $3.69 ($11,059)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Clarke C. Boyd Director | 2014-08-06 | Purchase | +3,000 | $3.69 | $11,059 | 15,500 | D |
| Open-market purchases · 3,000 sh · avg $3.69 · $11,059 | |||||||
Loading xslF345X03/doc4.xml…